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Data obtained in lizards infected with live bacteria suggest that fever may be beneficial to their
survival. An adaptive value of fever has also been inferred in mammals, but the results are
equivocal. Findings that certain leukocyte functions are enhanced in vitro at high temperatures
have provided a possible explanation for the alleged benefits offever. However, serious questions
exist as to whether results from experiments in ectotherms' and in vitro can properly be
extrapolated to in vivo endothermic conditions. Indeed, various studies have yielded results
inconsistent with the survival benefits attributed to fever, and fever is not an obligatory feature of
all infections under all conditions. Certainly, thewidespread use ofantipyretics, without apparent
adverse effects on the course of disease, argues against fever having great benefit to the host. In
sum, although fever is a cardinal manifestation of infection, conclusive evidence that it has
survival value in mammals is still lacking.
Fever is probably the oldest and best known manifestation of infectious disease
[1,2]. It has been the subject ofstudy and comment for well over 2,000 years, yet it is
still a matter ofcontroversy whether it has important adaptive value or whether it is a
harmful or trivial side effect in the host's response to infection. Although febrile illness
was alternately praised and feared during early times [2], a rise in temperature
gradually came to beviewed as an attempt ofNature to heal itselfand, therefore, to be
beneficial [3]. Indeed, fever was often induced as a therapeutic measure, until the
widespread and apparently harmless use ofantipyretics seemed to refute its beneficial
effects. But recently interest in the potential benefits of fever has been revived by
findings that fever may have survival value in some infected ectotherms, and that
certain host defense responses are enhanced in vitro by high temperature. There is as
yet no direct evidence that these results apply equally to endotherms in vivo. The
purpose ofthis paper is toreview the available evidence and tospeculate on thepossible
significance ofthe febrile reaction in the outcome ofinfection.
FEVER AND SURVIVAL IN ECTOTHERMS
The strongest experimental evidence in favor ofthe adaptivevalue offever probably
comes from the elegant studies of Kluger and his associates in ectotherms. They
demonstrated that the desert iguana, Dipsosaurus dorsalis, which thermoregulates
fairly precisely and develops a behavioral fever following injection ofvarious reptilian
'Ectothermy defines a pattern of thermoregulation in which body temperature is actively maintained
within a fairly narrow range, largely by behaviorally regulated heat uptake from or loss to the environment.
Reptiles, fishes, and amphibians are ectotherms. Mammals and birds are endotherms, i.e., their body
temperature depends on a high and controlled rate of heat production and autonomically regulated heat
exchange with the environment.
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pathogens [4], survives infection with live A. hydrophila when either placed in [5] or
given the opportunity to select [6] a warm environment in a thermal gradient, i.e.,
when enabled to raise its body temperature. Animals maintained in a cool environment
that prevented them from raising their body temperature promptly died. The adminis-
tration of antipyretics prevented the behavioral fever and also led to death [6].
Subsequently, Covert and Reynolds [7] found that the survival of goldfish infected
with live A. hydrophila was similarly enhanced when they were allowed to choose a
warm environment. Kluger et al. undertook their original experiments in ectotherms
because the febrile rise oftheseanimals, lacking or possessing only minimal autonomic
means of control, can be obviated simply by preventing the animals from selecting a
warmer microclimate, thereby permitting the effect of temperature on survival to be
more readily isolated. Since infectious fevers can also beinduced in certain amphibians
(reviewed by [8,9]) and even in invertebrates (reviewed by [101)-albeit their effects
on survival have not yet been studied-it is often stated that any phenomenon that has
withstood evolutionary pressures for so long must be good! Unfortunately, Kluger's
findings in iguanid lizards could not be replicated in several families ofcordylid lizards
by Laburn et al. [11], who were unable to evoke a febrile response in these more
primitive animals when they were injected with killed A. hydrophila, whether they
placed the animals in a warm environment or allowed them to choose a thermoprefer-
endum in a gradient. Indeed, their animals, injected or not, all selected identical
temperatures rather lower than those chosen by Kluger's animals. It would seem,
therefore, that the available data do not permit generalization about the ubiquity of
fever in ectotherms, let alone its benefits. More studies are needed using a greater
variety ofpathogenic and host species to elucidate these conflicting results.
It is uncertain, in any event, whether results in reptiles can readily be transferred to
mammals, since among other reasons host responses to pathogens are vastly more
complex in the latter. Indeed, Bernheim et al. [12] could find no difference between
infected and noninfected iguanid lizards in a variety of leukocyte functions that are
characteristic of mammalian host defense responses; they also could not demonstrate
any effect oftemperature on these mechanisms. The only difference that emerged was
that the bacterial count at the site of inoculation was reduced in the animals that had
developed a fever. They concluded, therefore, that fever, i.e., heat, may enhance the
local inflammatory response, perhaps by facilitating leukocyte migration to the
infected site. It should be noted, however, that the measurement of these nonfebrile
reactions was performed 12 hours after bacterial challenge, i.e., beforethey areusually
evident in endothermic systems. Grieger and Kluger [13] subsequently reported that
the plasma iron levels of infected lizards are reduced as compared to noninfected
controls. Iron is an essential co-factor for the growth of many bacteria [14], so that its
reduction inhibits growth, an effect which is enhanced by high temperature [15]. In
some lizards, therefore, it may be that fever, in synergism with low iron, reduces the
bacterial count and thereby enhances survival. Ifso, fever may indeed represent a vital
host defense response in iguanid lizards, which apparently lack at this phylogenetic
time-point other, more complex, host defense mechanisms.
FEVER AND SURVIVAL IN ENDOTHERMS
Only a few studies havespecifically investigated whether the absenceofa febrile rise
also may correlate with low survival rates in endotherms. The results have been
ambiguous. Kluger and Vaughn [16] found that the rise in bodytemperature ofrabbits
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infected with live P. multocida correlated with survival, with the greatest benefit
occurring when the rise was on the order of 1.50-2.25° C. Fevers above or below this
level were detrimental to survival; most deaths occurred within 30 hours after
challenge. Unfortunately, absolute temperatures were not reported in this study so that
these results cannot be related to actual febrile heights; febrile rises per se are subject
to many variables and bear no consistent relation to febrile heights [17]. Paradoxically,
the systemic administration of antipyretics (sodium salicylate and acetaminophen
co-infused continuously) increased the survival rates of the infected rabbits, albeit
their body temperatures were reduced by this treatment [18]. To exclude non-
antipyretic effects of the drugs on survival, Vaughn et al. [19] then continuously
infused sodium salicylate directly into the pre-optic area ofrabbits, beginning one hour
before injection of live P. multocida. Under these conditions, the animals' tempera-
tures rose approximately 0.70C, to 40.20C, as compared with 1.50C (410C) in the
control animals. The former stabilized at this level at circa 17 hours, when suddenly
their temperatures increased rapidly to hyperpyrexic levels. All the animals receiving
the antipyretic died during this phase, while the controls survived. Subsequently, these
authors [20] reported greater bacterial numbers in liver, lung, and spleen, but not
blood, ofthe salicylate-treated rabbits and suggested that the initially lower fever may
have caused the rapid multiplication ofbacteria, which then overwhelmed the animals.
However, the body temperatures of these animals were high enough that, in synergism
with the low plasma iron levels that should have prevailed throughout the study period
[15], bacterial reproduction would have been impaired. There is a further apparent
incongruity. In most cases, when the infectious burden becomes too great, the affected
animals develop septic shock, become moribund, and die in hypothermia. Indeed, in
this regard, febrile heights are not simply determined by the severity of infection since
lethal and sublethal infections induce the same average febrile temperatures [21].
Hence, the hyperpyrexia of Vaughn's rabbits could have been due to other factors. The
pattern of its development suggests that a disorganization of the thermoregulatory
system may have occurred, resulting in a fulminating hyperpyrexia, as though the
usual "hyperthermic ceiling" had been broken. A similar "escape" phenomenon has
been observed in rats infected with live S. enteritidis whose fevers were being depressed
by pre-optic heating; it did not, however, result in increased deaths [Banet M: personal
communication]. It should also be noted that, in these studies, the animals were
challenged by the intravenous administration of a rather large dose of bacteria.
Although evidently tolerable, since the controls survived, these conditions do not
adequately mimic those of real life where microorganisms typically enter the body
through the skin, or the respiratory, gastrointestinal, or urogenital tracts, and variable
periods pass during which an array of host defense mechanisms are marshalled that do
not always include fever [22]. Hence, these results in rabbits are insufficient to permit
general conclusions about the benefits of fever.
Indeed, contrary evidence was adduced by Banet [23,24]. He enhanced the febrile
response ofrats to live S. enteritidis by cooling their pre-optic anterior hypothalamus, a
procedure which stimulates the animals to maintain higher body temperatures, and
found that this treatment decreased survival. Fever in these animals peaked at circa
410C, a temperature which normally is not harmful to rats and which significantly
inhibits the growth of S. enteritidis. Under these conditions, the metabolic rate during
the rising phase of fever was not increased significantly above the levelof the infected
controls. On the other hand, when the rats' spinal cords were cooled, their metabolic
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rate increased by 40 percent, but the normal febrile rise was not affected because the
extra heat thus produced was taken up by the cool thermodes. Yet survival increased.
Banet concluded, therefore, that some response associated with the production of fever
enhances the defenses ofthe infected host, while the resulting rise in temperature per se
may depress them. His hypothesis is further discussed in another paper in this
symposium.
Data regarding the effect of fever on the outcome of infections in humans are also
few and ambiguous. For instance, in one study [25] no correlation between fever and
survival was found, while in others [26-29] a correlation was observed. However, in
these surveys, the patients all were treated, which would affect prognosis. Since the
available diagnostic and therapeutic procedures have become more effective in recent
years, thereby presumably enhancing survival, these could have biased the latter
results (since 1978) as compared with the earlier ones (through 1966).
Other studies often cited supporting or refuting a beneficial role for fever in infected
mammals (reviewed by [8,30,31]) are not directly relevant to the issue because, in
most instances, body temperatures were altered by the induction ofhypo- or hyperther-
mia, a procedure which does not result in a shift ofthe set-point temperature but rather
elicits thermoregulatory mechanisms different from those evoked during fever produc-
tion. It also involves additional stress to the hosts. Moreover, in many cases the animals
were challenged with endotoxins rather than with live organisms; some also received
various drugs. Indeed, a number of species do not ordinarily develop a fever but rather
become hypothermic in response to endotoxic injections-e.g., rats, mice, hamsters-
without apparent untoward consequences. Yet these species do mount fevers against
live bacterial challenges. Since repeated exposure to endotoxins causes the develop-
ment oftolerance to their febrile effects and, indeed, enhances survival, either fever per
se is not necessary for survival or the responses to systemically injected endotoxins are
not relevant to the question of the benefits of fever. Therefore, those studies will not be
considered here.
ANTIPYRESIS AND SURVIVAL
Since the use of antipyretics is a prototypical part of the home or medically
prescribed treatment ofmost infectious diseases with, in general, no untoward effect on
the course ofthe disease, it may be contended that the correlation between fever height
and survival revealed by the studies of Kluger and Vaughn [16,18] in rabbits is not
supported by common experience. For if the use of antipyretics led to morbidity and
mortality, this fact would presumably have been noted clinically and confirmed
experimentally long ago. In fact, the administration of large doses of prostaglandin
synthetase inhibitors to mice, rats, and rabbits suffering either chronic or acute
infections does not adversely affect survival or resistance to infection [32]. Further-
more, several recent studies [33-35] have demonstrated that the concatenation of
adaptive metabolic changes termed the acute-phase reaction which accompanies fever
and is induced by its endogenous mediator, interleukin-1, is not affected by cyclooxy-
genase inhibitors, albeit fever is depressed by these agents. Hence, in mammals, host
defense mechanisms would appear to exist which can contribute to recovery and
survival independently of fever. Indeed, fever is not an invariable occurrence in every
infection [22,36]. Moreover, individual variations in the febrile response arevery large
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and generally unpredictable. Some susceptible subjects appear to develop high fevers
at the slightest provocation, while others may not become febrile at all; within an
individual, this responsiveness may be characteristic [37]. It is true, however, that
these variations are more frequently seen in connection with so-called "trivial"
infections rather than with more widespread, systemic infections [36]. Nevertheless,
the variability in the occurrence of fever argues that it is not a vital requirement for
survival in all cases. Indeed, aged rats [38] exhibit reduced febrile responses while
neonates ofmost species do not generally develop fever in the first few days oflife [39],
yet they produce acute-phase reactants [38,40,41] and survive infection [38], suggest-
ing again that other factors in the more complex host defense responses of mammals
may have supplanted the apparent dependence of ectotherms on fever for survival.
TEMPERATURE AND MICROORGANISMS
It seems clear that exposure to hyperthermia in vitro generally reduces the growth of
many microorganisms [42,43]. The thermal susceptibility of spirochetes and trepo-
nemes is particularly well known. Indeed, fever therapy was a principal form of
treatment before the antibiotic era for syphilis, gonococcal infections, and chancroid.
However, the depressing effect ofhyperthermia on microbial growth is most prominent
at temperatures not usually observed during most infectious fevers, i.e., at tempera-
tures greater than 410C. Moreover, since most organisms possess a thermal range for
optimal growth, it might be expected that those with lower optimal temperatures
would be more easily affected by febrile temperatures, and that consequently fever
might be a crucial defense mechanism in infections caused by them. But, in fact,
thermolabile microbes such as T. pallidum and N. gonorrhea rarely induce tempera-
tures that would cause them to be destroyed, while microbes that evoke high
temperatures, like the malaria parasite, are unaffected by these temperatures [42]. It
would seem, therefore, that fever as an antimicrobial mechanism may be of less
importance to the infected mammalian host than has been thought.
On the other hand, the interaction ofhigh temperature with a low availability ofiron
[15] could be potentially beneficial. Nevertheless, these data have to be interpreted
with caution because in vitro experiments involve important variables other than
temperature that may affect the results [44]. For example, differences in the chemical
composition of the growth medium, its pH and 02 content all affect the thermal
susceptibility ofthe organisms. The phase ofgrowth ofthe organisms also is important,
since bacteria that are dividing rapidly are less resistant to increases in temperature
than bacteria in the stationary phase. These variables have not been controlled
consistently. Moreover, most studies have been conducted under conditions in which
the high temperature was sustained for prolonged hours, which is not the usual
occurrence in infections. Natural fever is characterized by variations in temperature of
-20C over a few hours, which could allow microorganisms to adapt to degrees of
hyperthermia that otherwise would be inhibitory. Also, while there is an implicit
assumption that lower bacterial counts signify less severe infection, as already
mentioned this does not necessarily correlate with fever height [21] or bear any direct
relation to the organisms' virulence and infectivity [45]. Moreover, organisms often
develop resistance to the host's defenses [46]. Finally, it should be noted that many of
the metabolic changes accompanying infection themselves contribute to increased host
resistance against the pathogens [47].
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TABLE 1
Effects of Temperature Variations on Some Leukocyte Functions in Vitro
Effective Temperatures (OC)
Unchanged or
Host Defense Function Enhanced Depressed Reference
PMN Motility 40-42 [48-50]
40 [511
Phagocytosis (S. aureus) 41-43 [52]
38-40 [53]
(Opsonization) 41 [54]
Bactericidal activity
E. coli, S. typhimurium, (PMN) 39-40 (MN) 39-40 [55]
L. monocytogenes
S. aureus (PMN) 39-40 [55]
E. coli 39-41 [56]
Pneumococci 39-41 [56]
40 [51]
NK activity 39-40 [57]
40-42 [58]
Lymphocyte proliferation 36-38 *[59]
and activation (to diverse 39 [60]
mitogens and *IL-1) [55]
*[61]
(LPS) 39 [61]
(TH) 39.5 (B,Ts) 39.5 *[62]
40 [63]
Antibody synthesis 40 [64]
Interferon production 30-34 [65]
aAbbreviations: PMN = polymorphonuclear cells; MN = monocytes; IL-1 =
interleukin-1; NK = natural killer cells; LPS - lipopolysaccharide (endotoxin); TH
= helper T cells; B = B lymphocytes; T, = suppressor T cells.
FEVER AND IMMUNE REACTIONS
Recently, data have been provided indicating that fever may potentiate certain
immunoregulatory responses. These findings have been taken to support the view that
fever represents a basic, beneficial host defense mechanism. Thus, it has been proposed
that the role of fever in endotherms may be to enhance the nonfebrile reactions to
infection, i.e., to function as an "immunological amplifier." However, the evidence for
this proposition all comes from in vitro data. Although in vitro studies eliminate many
of the complicating factors inherent in in vivo studies, can the results be safely
extrapolated to in vivo conditions? Indeed, many studies have been reported on the
temperature sensitivity of various leukocyte functions (reviewed by [22]), but the
results are equivocal (Table 1). Enhancement, when it occurs, does so at temperatures
that, again, generally are at levels not usually attained during most infectious diseases.
However, significantly, those responses which are induced specifically by interleukin-1
(*IL-1, Table 1), the endogenous mediator which activates the concatenation of host
defense responses [22,66], appear to be consistently enhanced at febrile temperatures.
It is possible, therefore, that IL-1-driven febrileand nonfebrile responses haveadaptive
value when occurring in concert. But it should be reiterated that generalizations from
these in vitro conditions must be made with care, since, in order to demonstrate the
effect of heat on these reactions, all other factors were controlled. In vivo, of course,
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these other factors do co-exist and probably influence the results, thereby perhaps
minimizing the importance of heat alone. For example, Brandt and Banet [67] have
suggested that the immunostimulation associated with fever may be due to factors
other than the rise in temperature per se and have implicated the neuroendocrine
system in this effect. It may be supposed, therefore, that if all the actions of IL-1 are
present together, the defenses ofthe host are at their optimal levels; but ifone, such as
fever, is absent, no great consequence would ensue because of the redundancy of the
system.
CONCLUSIONS
The importance of fever as a clinical diagnostic and prognostic sign of disease-
particularly infectious disease-cannot be minimized. But it isamusing to note that for
most people, and parents especially, fever is a bad sign that should be prevented.
Schmitt [68] coined the phrase "fever phobia" to describe this concern. Yet it is
generally accepted that high fevers (greater than 40.50 C) can havedetrimental effects
on the host, including dehydration, delirium, focal lesions ofcertain organs, cardiopul-
monary strain, and negative nutrient balance. Even moderate fevers, ifprolonged, can
be detrimental. It-follows that fevers of any degree may be a risk to certain patient
categories and therefore should be abated [39]. But it is not yet resolved whether a
moderate febrile rise, although tolerable, is in fact beneficial to endothermic hosts,
even though it may convey some benefits to certain ectotherms. The available data
indicate that fever almost certainly is not essential to the host defense ofendotherms.
But it may have an enhancing role in connection with the manifold interleukin-
1-induced nonfebrile reactions that usually occur following an infectious challenge.
Clearly, many more studies are needed to clarify whether the development of fever in
response to infection is adaptive, maladaptive, or irrelevant in mammalian, and
especially human, hosts. A most difficult task will be to separate fever from all the
other coincident events influencing recovery and survival.
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